MedPath

The effects of high dose of selenium in the treatment of patient with severe sepsis

Phase 2
Conditions
Severe sepsis.
Systemic Inflammatory Response Syndrome of infectious origin with organ failure Severe sepsis
Registration Number
IRCT201212082887N4
Lead Sponsor
Vice chancellor for research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
51
Inclusion Criteria

Patient with suspected or documented diagnosis of infection with at least one of these: White blood cell (WBC) in sterile regions, Perforated viscera; Radiologic evidence of pneumonia and infected sputum; High risk infection such as Cholangitis; and at least three of the following: Body temperature above 38 degrees Celsius or under 36; Heart rate greater than 90 beat per minute without consuming any medication, Respiratory rate more than 20 per minute or arterial pressure of carbon dioxide less than 32 millimeter of mercury with mechanical ventilation; White blood cells more than 12000 or less than 1000; more than 10 percent band Neutrophils.
Exclusion criteria: more than 24 hours of diagnosis of sever sepsis; high probability death due to a nonspecific cause (renal insufficiency, hepatic encephalopathy, etc) within the first 28 days; pregnancy or lactating; Age less than 16 years; dissatisfaction of patient or his family to enter the study; patients with Cancer

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality. Timepoint: Mortality within 28 days of after diagnosis with severe sepsis. Method of measurement: Counting the number of patient died.;Length of ICU stay. Timepoint: Number of bed days in ICU since entry into the research. Method of measurement: Registration for beding in ICU.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath